Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression

Development

Volumn 139, Issue 4, 2012, Pages 749-759

  Ishimura, Akihiko ^a   Minehata, Ken ichi ^b   Terashima, Minoru ^a   Kondoh, Gen ^c   Hara, Takahiko ^b   Suzuki, Takeshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Cdkn1a; Cell proliferation; Jmjd5 (Kdm8); Mouse

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; HISTONE DEMETHYLASE; HISTONE H3; LYSINE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; EPIGENETICS; FEMALE; FIBROBLAST; GENETICS; GROWTH RETARDATION; LETHALITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION REGULATION; HISTONES; HUMANS; IN SITU HYBRIDIZATION; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LYSINE; MICE; MICE, KNOCKOUT; RNA, SMALL INTERFERING;

MUS;

EID: 84862909294     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.074138     Document Type: Article

References (51)

1. Abidi, F. E., Miano, M. G., Murray, J. C. and Schwartz, C. E. (2007). A novel mutation in the PHF8 gene is associated with X-linked mental retardation with cleft lip/cleft palate. Clin. Genet. 72, 19-22.
2. Agger, K., Cloos, P. A., Rudkjaer, L., Williams, K., Andersen, G., Christensen, J. and Helin, K. (2009). The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev. 23, 1171-1176.
3. Ando, H., Haruna, Y., Miyazaki, J., Okabe, M. and Nakanishi, Y. (2000). Spermatocyte-specific gene excision by targeted expression of Cre recombinase. Biochem. Biophys. Res. Commun. 272, 125-128.
4. Barradas, M., Anderton, E., Acosta, J. C., Li, S., Banito, A., Rodriguez- Niedenführ, M., Maertens, G., Banck, M., Zhou, M. M., Walsh, M. J. et al. (2009). Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev. 23, 1177-1182.
5. Carter, S. and Vousden, K. H. (2009). Modifications of p53: competing for the lysines. Curr. Opin. Genet. Dev. 19, 18-24.
6. Ciemerych, M. A. and Sicinski, P. (2005). Cell cycle in mouse development. Oncogene 24, 2877-2898.
7. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J. and Leder, P. (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684.
8. Eggan, K., Akutsu, H., Loring, J., Jackson-Grusby, L., Klemm, M., Rideout, W. M., 3rd, Yanagimachi, R. and Jaenisch, R. (2001). Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. USA 98, 6209-6214.
9. Ehrbrecht, A., Müller, U., Wolter, M., Hoischen, A., Koch, A., Radlwimmer, B., Actor, B., Mincheva, A., Pietsch, T., Lichter, P. et al. (2006). Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components. J. Pathol. 208, 554-563.
10. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
11. Fukuda, T., Tokunaga, A., Sakamoto, R. and Yoshida, N. (2011). Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephaly. Mol. Cell. Neurosci. 46, 614-624.
12. Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F. et al. (1996). The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023.
13. Hakem, R., de la Pompa, J. L., Elia, A., Potter, J. and Mak, T. W. (1997). Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation. Nat. Genet. 16, 298-302.
14. Han, V. K. and Carter, A. M. (2001). Control of growth and development of the feto-placental unit. Curr. Opin. Pharmacol. 1, 632-640.
15. Hayami, S., Yoshimatsu, M., Veerakumarasivam, A., Unoki, M., Iwai, Y., Tsunoda, T., Field, H. I., Kelly, J. D., Neal de Yamaue, H. et al. (2010). Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol. Cancer 9, 59.
16. He, J., Kallin, E. M., Tsukada, Y. and Zhang, Y. (2008). The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b). Nat. Struct. Mol. Biol. 15, 1169-1175.
17. Hsia, D. A., Tepper, C. G., Pochampalli, M. R., Hsia, E. Y., Izumiya, C., Huerta, S. B., Wright, M. E., Chen, H. W., Kung, H. J. and Izumiya, Y. (2010). KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc. Natl. Acad. Sci. USA 107, 9671-9676.
18. Inagaki, T., Tachibana, M., Magoori, K., Kudo, H., Tanaka, T., Okamura, M., Naito, M., Kodama, T., Shinkai, Y. and Sakai, J. (2009). Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice. Genes Cells 14, 991-1001.
19. Jensen, L. R., Amende, M., Gurok, U., Moser, B., Gimmel, V., Tzschach, A., Janecke, A. R., Tariverdian, G., Chelly, J., Fryns, J. P. et al. (2005). Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76, 227-236.
20. Jones, M. A., Covington, M. F., DiTacchio, L., Vollmers, C., Panda, S. and Harmer, S. L. (2010). Jumonji domain protein JMJD5 functions in both the plant and human circadian systems. Proc. Natl. Acad. Sci. USA 107, 21623-21628.
21. Kanki, H., Suzuki, H. and Itohara, S. (2006). High-efficiency CAG-FLPe delete mice in C57BL/6J background. Exp. Anim. 55, 137-141.
22. Kimura, H., Hayashi-Takanaka, Y., Goto, Y., Takizawa, N. and Nozaki, N. (2008). The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct. Funct. 33, 61-73.
23. Kitajima, S., Miki, T., Takegami, Y., Kido, Y., Noda, M., Hara, E., Shamma, A. and Takahashi, C. (2011). Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling. Oncogene 30, 737-750.
24. Klose, R. J., Kallin, E. M. and Zhang, Y. (2006). JmjC-domain-containing protein and histone demethylation. Nat. Rev. Genet. 7, 725-727.
25. Koivisto, A. M., Ala-Mello, S., Lemmelä, S., Komu, H. A., Rautio, J. and Järvelä, I. (2007). Screening of mutations in the PHF8 gene and identification of a novel mutation in a Finnish family with XLMR and cleft lip/cleft palate. Clin. Genet. 72, 145-149.
26. Krogan, N. J., Kim, M., Tong, A., Golshani, A., Cagney, G., Canadien, V., Richards, D. P., Beattie, B. K., Emili, A., Boone, C. et al. (2003). Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol. Cell. Biol. 23, 4207-4218.
27. Lagger, G., O'Carroll, D., Rembold, M., Khier, H., Tischler, J., Weitzer, G., Schuettengruber, B., Hauser, C., Brunmeir, R., Jenuwein, T. et al. (2002). Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21, 2672-2681.
28. Laumonnier, F., Holbert, S., Ronce, N., Faravelli, F., Lenzner, S., Schwartz, C. E., Lespinasse, J., Van Esch, H., Lacombe, D., Goizet, C. et al. (2005). Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J. Med. Genet. 42, 780-786.
29. Li, B., Carey, M. and Workman, J. L. (2007). The role of chromatin during transcription. Cell 128, 707-719.
30. Liu, G., Bollig-Fischer, A., Kreike, B., van de Vijver, M. J., Abrams, J., Ethier, S. P. and Yang, Z. Q. (2009). Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 28, 4491-4500.
31. Liu, P., Jenkins, N. A. and Copeland, N. G. (2003). A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res. 13, 476-484.
32. Lu, P. J., Sundquist, K., Baeckstrom, D., Poulsom, R., Hanby, A., Meier-Ewert, S., Jones, T., Mitchell, M., Pitha-Rowe, P., Freemont, P. et al. (1999). A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J. Biol. Chem. 274, 15633-15645.
33. Martin, C. and Zhang, Y. (2005). The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 6, 8365-8370.
34. Migliorini, D., Lazzerini Denchi, E., Danovi, D., Jochemsen, A., Capillo, M., Gobbi, A., Helin, K., Pelicci, P. G. and Marine, J. C. (2002). Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell. Biol. 22, 5527-5538.
35. Mosammaparast, N. and Shi, Y. (2011). Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79, 155-179.
36. Nagy, A., Gertsenstein, M., Vintersten, K. and Behringer, R. (2003). Manipulating the Mouse Embryo: A Laboratory Manual, 3rd edition, pp. 371-373. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
37. Northcott, P. A., Nakahara, Y., Wu, X., Feuk L., Ellison, D. W., Croul, S., Mack, S., Kongkham, P. N., Peacock, J., Dubuc, A. et al. (2009). Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat. Genet. 41, 465-472.
38. Pedersen, M. T. and Helin, K. (2010). Histone demethylases in development and disease. Trends Cell Biol. 20, 662-671.
39. Rantakari, P., Nikkilä, J., Jokela, H., Ola, R., Pylkäs, K., Lagerbohm, H., Sainio, K., Poutanen, M. and Winqvist, R. (2010). Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice. Hum. Mol. Genet. 19, 3021-3029.
40. Ruland, J., Sirard, C., Elia, A., MacPherson, D., Wakeham, A., Li, L., de la Pompa, J. L., Cohen, S. N., Mak, T. W. (2001). P53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc. Natl. Acad. Sci. USA 98, 1859-1864.
41. Schaft, D., Roguev, A., Kotovic, K. M., Shevchenko, A., Sarov, M., Shevchenko, A., Neugebauer, K. M. and Stewart, A. F. (2003). The histone 3 lysine 36 methyltransferase, SET2, is involved in transcriptional elongation. Nucleic Acids Res. 31, 2475-2482.
42. Steinman, H. A., Sluss, H. K., Sands, A. T., Pihan, G. and Jones, S. N. (2004). Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth. Oncogene 23, 303-306.
43. Suzuki, A., de la Pompa, J. L., Hakem, R., Elia, A., Yoshida, R., Mo, R., Nishina, H., Chuang, T., Wakeham, A., Itie, A. et al. (1997). Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11, 1242-1252.
44. Tateishi, K., Okada, Y., Kallin, E. M. and Zhang, Y. (2009). Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458, 757-761.
45. Terashima, M., Ishimura, A., Yoshida, M., Suzuki, Y., Sugano, S. and Suzuki, T. (2010). The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase. Biochem. Biophys. Res. Commun. 399, 238-244.
46. van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J. et al. (2009). Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41, 521-523.
47. Wood, A. and Shilatifard, A. (2006). Transcriptional blackjack with p21. Genes Dev. 20, 643-647.
48. Xiang, Y., Zhu, Z., Han, G., Ye, X., Xu, B., Peng, Z., Ma, Y., Yu, Y., Lin, H., Chen, A. et al. (2007). JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl. Acad. Sci. USA 104, 19226-19231.
49. Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L. and Rossant, J. (1993). Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118, 489-498.
50. Yang, Z. Q., Imoto, I., Fukuda, Y., Pimkhaokham, A., Shimada, Y., Imamura, M., Sugano, S., Nakamura, Y. and Inazawa, J. (2000). Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res. 60, 4735-4739.
51. Yoshida, M., Ishimura, A., Terashima, M., Enkhbaatar, Z., Nozaki, N., Satou, K. and Suzuki, T. (2011). PLU1 histone demethylase decreases the expression of KAT5 and enhances the invasive activity of the cells. Biochem. J. 437, 555-564.